Cart (0 Items)
Your cart is currently empty.
View ProductsSize | |
---|---|
Brand | |
Product type | |
Clonality | |
Expression system | |
Applications |
Product name | Prezalumab Biosimilar - Anti-ICOSLG, B7-H2, B7RP-1, CD275 mAb - Research Grade |
---|---|
Source | CAS 1523164-68-2 |
Species | Homo sapiens |
Expression system | Mammalian cells |
Purity | >85% |
Buffer | PBS buffer PH7.5 |
Delivery condition | Blue ice (+4°C) |
Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
Storage condition | store at -80°C |
Brand | ProteoGenix |
Applications | ELISA,WB |
Aliases /Synonyms | Prezalumab,AMG 557,MEDI-5872,ICOSLG, B7-H2, B7RP-1, CD275,anti-ICOSLG, B7-H2, B7RP-1, CD275 |
Reference | PX-TA1417 |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Isotype | IgG2-kappa |
Clonality | Monoclonal Antibody |
Prezalumab has been investigated for the treatment of Sjogren’s syndrome Cutaneous Lupus Erythematosus, Psoriasis, and Systemic Lupus Erythematosus (SLE).
Prezalumab Biosimilar - Anti-ICOSLG, B7-H2, B7RP-1, CD275 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Related products
Reviews
Il n’y a pas encore d’avis.